Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
It is the science being supported by the Moonshot that will accelerate progress across the entire cancer continuum.
The trial will soon have nearly 40 study arms testing different targeted therapies.
Researchers studied older women with breast cancer to discover why some people are particularly susceptible to “chemo brain.”
A new study links poor access to affordable, healthy food to an increased risk of cancer death.
This minimally invasive approach may reduce the burden on children with diffuse midline glioma.
We’re interested in assessing how diet affects health—but in the context of the what, where, when, why, and how we eat.
This is, without a doubt, a time of great hope in cancer research.
In non-small cell lung cancer, new drugs like brigatinib and crizotinib can dramatically shrink tumors with an ALK alteration.
The dual-stain test addresses a critical question: How often should HPV-positive women undergo repeat screenings for cervical cancer?
The program proved as accurate as experienced pathologists at diagnosing adenocarcinomas and squamous cell carcinomas.
Because so few people diagnosed with SCLC survive for even a year despite treatment, an advance in survival rate is quite significant.
The lead researcher called the results “tantalizing, but not yet good enough.”
A win–win for making progress against cancer
Certain cancer treatments can damage the heart and the cardiovascular system.
Scientists at Division of Cancer Prevention and the Center for Global Health collaborate to to study cancers nationally and internationally.
A conversation with Supriya Mohile, MD
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.